The Board has at its meeting held today 13.06.2025 considered and took the note of the resignation of Mr. Kuldip Parekh from the post of Chief Financial Officer of the Company w.e.f. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 2.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Adline Chem Lab's board, at a meeting on June 13, 2025, accepted the resignation of Mr. Kuldip Parekh as Chief Financial Officer and appointed Mr. Hardik Jitendrabhai Vaghasiya as the new CFO. The board also approved the resignation of Company Secretary Mrs. Ritu Singh, replacing her with Ms. Akshita Khandelwal, and appointed two new Non-Executive Independent Directors, Mr. Him Vyas and Mr. Krish Patel. The 37th Annual General Meeting has been scheduled for July 11, 2025 via video conferencing, and M/s. Ishit Vyas & Co. has been appointed as Secretarial Auditor for five financial years (FY2025-26 to FY2029-30). In a notable strategic shift, the company also approved an alteration to its main objects clause to add businesses in renewable energy (solar power plants), engineering and procurement contracting, and commodity trading — areas very different from its existing chemical/laboratory business. Shareholder approval via special resolution will be sought at the upcoming AGM. The registered office is also being shifted within Ahmedabad.
The simultaneous exit of the CFO and Company Secretary, followed by quick replacements, suggests routine succession rather than distress — but investors should watch the major change in business objects, as the company is expanding far beyond chemicals into solar energy, infrastructure, and commodity trading, which could materially reshape its future revenue mix and risk profile.